Michael Schurr
Concepts (385)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pseudomonas aeruginosa | 56 | 2025 | 356 | 5.960 |
Why?
| | Gene Expression Regulation, Bacterial | 32 | 2018 | 327 | 3.760 |
Why?
| | Bacterial Proteins | 34 | 2019 | 954 | 3.060 |
Why?
| | Trans-Activators | 11 | 2018 | 405 | 2.510 |
Why?
| | Corynebacterium Infections | 6 | 2024 | 42 | 2.190 |
Why?
| | Corynebacterium | 7 | 2024 | 49 | 2.160 |
Why?
| | Pseudomonas Infections | 16 | 2025 | 221 | 1.700 |
Why?
| | Biofilms | 19 | 2021 | 278 | 1.620 |
Why?
| | Alginates | 19 | 2020 | 49 | 1.510 |
Why?
| | Sigma Factor | 16 | 2013 | 43 | 1.040 |
Why?
| | Mice, Nude | 4 | 2024 | 682 | 0.990 |
Why?
| | Transcription, Genetic | 18 | 2014 | 1495 | 0.980 |
Why?
| | Anti-Bacterial Agents | 13 | 2026 | 1906 | 0.960 |
Why?
| | Cell-Penetrating Peptides | 1 | 2025 | 20 | 0.880 |
Why?
| | Gentamicins | 1 | 2025 | 51 | 0.870 |
Why?
| | Drug Delivery Systems | 2 | 2026 | 379 | 0.870 |
Why?
| | Cystic Fibrosis | 19 | 2020 | 1158 | 0.850 |
Why?
| | Regulon | 5 | 2014 | 34 | 0.760 |
Why?
| | Urinary Tract Infections | 1 | 2025 | 202 | 0.740 |
Why?
| | Lasers, Solid-State | 1 | 2021 | 22 | 0.680 |
Why?
| | Titanium | 1 | 2021 | 81 | 0.660 |
Why?
| | Transcription Factors | 10 | 2014 | 1739 | 0.580 |
Why?
| | Pyocyanine | 1 | 2018 | 3 | 0.550 |
Why?
| | Protein Processing, Post-Translational | 2 | 2018 | 477 | 0.530 |
Why?
| | Staphylococcus aureus | 2 | 2023 | 454 | 0.500 |
Why?
| | Genes, Bacterial | 15 | 2010 | 166 | 0.480 |
Why?
| | Oligopeptides | 1 | 2018 | 268 | 0.470 |
Why?
| | Nitrites | 6 | 2021 | 89 | 0.450 |
Why?
| | Mice | 22 | 2025 | 18329 | 0.430 |
Why?
| | Promoter Regions, Genetic | 11 | 2014 | 1255 | 0.410 |
Why?
| | Quorum Sensing | 5 | 2016 | 79 | 0.390 |
Why?
| | Mice, Inbred NOD | 4 | 2023 | 610 | 0.390 |
Why?
| | Glycolipids | 1 | 2013 | 52 | 0.390 |
Why?
| | Bacteria | 4 | 2020 | 889 | 0.380 |
Why?
| | Culture Media | 5 | 2024 | 160 | 0.380 |
Why?
| | Locomotion | 1 | 2013 | 105 | 0.380 |
Why?
| | Gene Expression Profiling | 10 | 2018 | 1782 | 0.370 |
Why?
| | Virulence | 10 | 2018 | 278 | 0.360 |
Why?
| | Molecular Sequence Data | 19 | 2014 | 2929 | 0.340 |
Why?
| | Animals | 28 | 2026 | 38030 | 0.330 |
Why?
| | Composite Resins | 2 | 2021 | 106 | 0.330 |
Why?
| | Edetic Acid | 2 | 2021 | 47 | 0.330 |
Why?
| | Heat-Shock Response | 3 | 2013 | 77 | 0.320 |
Why?
| | Base Sequence | 15 | 2014 | 2187 | 0.320 |
Why?
| | Coinfection | 2 | 2023 | 141 | 0.310 |
Why?
| | Disinfectants | 2 | 2021 | 46 | 0.310 |
Why?
| | Oligonucleotide Array Sequence Analysis | 6 | 2013 | 758 | 0.300 |
Why?
| | DNA-Binding Proteins | 5 | 2009 | 1497 | 0.290 |
Why?
| | Hexosyltransferases | 2 | 2010 | 6 | 0.290 |
Why?
| | Epithelial Cells | 3 | 2006 | 1125 | 0.280 |
Why?
| | Cryoprotective Agents | 1 | 2008 | 11 | 0.280 |
Why?
| | Cyanides | 1 | 2009 | 56 | 0.280 |
Why?
| | Skin Diseases | 2 | 2023 | 149 | 0.270 |
Why?
| | Microbial Viability | 1 | 2008 | 90 | 0.270 |
Why?
| | Milk | 1 | 2008 | 119 | 0.260 |
Why?
| | Gene Deletion | 6 | 2013 | 387 | 0.260 |
Why?
| | Repressor Proteins | 3 | 2009 | 437 | 0.260 |
Why?
| | Staphylococcal Infections | 2 | 2023 | 388 | 0.260 |
Why?
| | Cryopreservation | 1 | 2008 | 110 | 0.260 |
Why?
| | Diabetes Mellitus, Experimental | 2 | 2021 | 198 | 0.250 |
Why?
| | Phosphorylation | 4 | 2018 | 1732 | 0.250 |
Why?
| | Mice, SCID | 2 | 2023 | 369 | 0.220 |
Why?
| | Re-Epithelialization | 3 | 2021 | 6 | 0.220 |
Why?
| | Hydrogen Cyanide | 1 | 2004 | 5 | 0.220 |
Why?
| | Disease Models, Animal | 6 | 2024 | 4556 | 0.210 |
Why?
| | Space Flight | 3 | 2010 | 71 | 0.210 |
Why?
| | Hexuronic Acids | 11 | 2014 | 23 | 0.210 |
Why?
| | Glucuronic Acid | 11 | 2014 | 25 | 0.210 |
Why?
| | Transcription Initiation Site | 3 | 2014 | 43 | 0.210 |
Why?
| | Lung | 5 | 2019 | 4108 | 0.200 |
Why?
| | Burns | 2 | 2019 | 376 | 0.200 |
Why?
| | Anti-Infective Agents | 1 | 2026 | 242 | 0.200 |
Why?
| | Bacterial Adhesion | 3 | 2019 | 109 | 0.190 |
Why?
| | Respiratory System | 1 | 2004 | 149 | 0.190 |
Why?
| | Azo Compounds | 2 | 2021 | 30 | 0.190 |
Why?
| | Rodentia | 2 | 2021 | 61 | 0.180 |
Why?
| | Streptococcus mutans | 1 | 2021 | 8 | 0.180 |
Why?
| | Dental Bonding | 1 | 2021 | 28 | 0.180 |
Why?
| | Sodium Nitrite | 2 | 2020 | 39 | 0.170 |
Why?
| | Aggregatibacter actinomycetemcomitans | 1 | 2021 | 27 | 0.170 |
Why?
| | Acinetobacter Infections | 1 | 2021 | 13 | 0.170 |
Why?
| | DNA, Bacterial | 4 | 2014 | 342 | 0.170 |
Why?
| | Coated Materials, Biocompatible | 2 | 2019 | 65 | 0.170 |
Why?
| | Acinetobacter baumannii | 1 | 2021 | 24 | 0.170 |
Why?
| | Iron | 4 | 2014 | 359 | 0.160 |
Why?
| | Wilderness | 1 | 2020 | 12 | 0.160 |
Why?
| | Epidermal Growth Factor | 1 | 2021 | 171 | 0.160 |
Why?
| | Drinking Water | 1 | 2022 | 97 | 0.160 |
Why?
| | Drug Resistance, Multiple, Bacterial | 1 | 2021 | 81 | 0.160 |
Why?
| | Mountaineering | 1 | 2020 | 36 | 0.160 |
Why?
| | Iraq War, 2003-2011 | 1 | 2021 | 164 | 0.160 |
Why?
| | Wound Infection | 1 | 2021 | 55 | 0.160 |
Why?
| | Surface Properties | 1 | 2021 | 410 | 0.160 |
Why?
| | Afghan Campaign 2001- | 1 | 2021 | 184 | 0.160 |
Why?
| | Microbial Interactions | 1 | 2020 | 19 | 0.160 |
Why?
| | Microarray Analysis | 2 | 2018 | 117 | 0.160 |
Why?
| | Chlorine Compounds | 1 | 2019 | 10 | 0.150 |
Why?
| | Skin, Artificial | 1 | 2019 | 4 | 0.150 |
Why?
| | Wound Healing | 3 | 2021 | 351 | 0.150 |
Why?
| | Decontamination | 1 | 2019 | 32 | 0.150 |
Why?
| | Heat-Shock Proteins | 2 | 1997 | 138 | 0.150 |
Why?
| | Oxides | 1 | 2019 | 51 | 0.150 |
Why?
| | Metabolic Networks and Pathways | 3 | 2020 | 187 | 0.150 |
Why?
| | Skin Transplantation | 1 | 2019 | 85 | 0.140 |
Why?
| | Bacterial Physiological Phenomena | 1 | 2019 | 60 | 0.140 |
Why?
| | Amino Acid Sequence | 11 | 2011 | 2154 | 0.130 |
Why?
| | Mutation | 8 | 2019 | 4085 | 0.130 |
Why?
| | Accidental Falls | 1 | 2020 | 222 | 0.130 |
Why?
| | Humans | 32 | 2026 | 144261 | 0.130 |
Why?
| | Models, Biological | 1 | 2005 | 1820 | 0.130 |
Why?
| | Operon | 2 | 2009 | 69 | 0.130 |
Why?
| | Gene Conversion | 1 | 1996 | 7 | 0.120 |
Why?
| | Aspergillus | 1 | 2016 | 18 | 0.120 |
Why?
| | Age Factors | 1 | 2024 | 3313 | 0.120 |
Why?
| | Amidohydrolases | 1 | 2016 | 32 | 0.120 |
Why?
| | Polyurethanes | 1 | 2016 | 38 | 0.120 |
Why?
| | Nitric Oxide | 2 | 2014 | 897 | 0.120 |
Why?
| | Multigene Family | 4 | 1994 | 203 | 0.120 |
Why?
| | Gallium | 1 | 2015 | 6 | 0.120 |
Why?
| | Severity of Illness Index | 1 | 2024 | 2917 | 0.120 |
Why?
| | Drosophila melanogaster | 1 | 2018 | 236 | 0.120 |
Why?
| | Aspartate Carbamoyltransferase | 1 | 1995 | 3 | 0.110 |
Why?
| | Dihydroorotase | 1 | 1995 | 3 | 0.110 |
Why?
| | Phenotype | 9 | 2014 | 3157 | 0.110 |
Why?
| | Microbial Sensitivity Tests | 4 | 2021 | 370 | 0.110 |
Why?
| | Intubation, Intratracheal | 1 | 2018 | 320 | 0.110 |
Why?
| | Tissue Engineering | 1 | 2019 | 440 | 0.110 |
Why?
| | Oxidoreductases Acting on CH-NH2 Group Donors | 2 | 2004 | 2 | 0.110 |
Why?
| | Gastrointestinal Microbiome | 1 | 2023 | 771 | 0.110 |
Why?
| | Proto-Oncogene Proteins c-sis | 1 | 2014 | 39 | 0.110 |
Why?
| | Splints | 1 | 2014 | 14 | 0.110 |
Why?
| | Multienzyme Complexes | 2 | 2004 | 67 | 0.110 |
Why?
| | Polysaccharides, Bacterial | 2 | 2014 | 67 | 0.110 |
Why?
| | Pseudomonas putida | 1 | 1995 | 42 | 0.100 |
Why?
| | Oxidoreductases | 2 | 2004 | 96 | 0.100 |
Why?
| | Escherichia coli | 5 | 1996 | 852 | 0.100 |
Why?
| | Microbiota | 1 | 2022 | 781 | 0.100 |
Why?
| | Catalase | 1 | 2014 | 130 | 0.100 |
Why?
| | Cyclic GMP | 1 | 2014 | 92 | 0.100 |
Why?
| | Flagella | 2 | 2011 | 27 | 0.100 |
Why?
| | Patient Selection | 1 | 2018 | 719 | 0.100 |
Why?
| | Host Factor 1 Protein | 2 | 2010 | 3 | 0.100 |
Why?
| | RNA Polymerase Sigma 54 | 2 | 2011 | 3 | 0.100 |
Why?
| | Vanadates | 1 | 2013 | 17 | 0.100 |
Why?
| | Fimbriae Proteins | 1 | 2013 | 25 | 0.100 |
Why?
| | Athletic Injuries | 1 | 2020 | 569 | 0.100 |
Why?
| | Mutant Proteins | 1 | 2013 | 106 | 0.100 |
Why?
| | Drug Resistance, Bacterial | 3 | 2020 | 196 | 0.100 |
Why?
| | DNA-Directed RNA Polymerases | 3 | 2000 | 63 | 0.100 |
Why?
| | Carbohydrate Dehydrogenases | 4 | 2000 | 11 | 0.100 |
Why?
| | Respiration, Artificial | 1 | 2018 | 707 | 0.090 |
Why?
| | Peptide Hydrolases | 1 | 2013 | 105 | 0.090 |
Why?
| | Plasmids | 3 | 2007 | 379 | 0.090 |
Why?
| | Female | 9 | 2025 | 77976 | 0.090 |
Why?
| | Pyruvic Acid | 1 | 2012 | 55 | 0.090 |
Why?
| | Pseudomonas Phages | 1 | 2011 | 3 | 0.090 |
Why?
| | Bacteriolysis | 1 | 2011 | 10 | 0.090 |
Why?
| | Mutation, Missense | 1 | 2013 | 340 | 0.090 |
Why?
| | Exopeptidases | 1 | 2011 | 1 | 0.080 |
Why?
| | Methacrylates | 2 | 2021 | 119 | 0.080 |
Why?
| | Pulmonary Surfactant-Associated Protein A | 1 | 2011 | 29 | 0.080 |
Why?
| | Delayed-Action Preparations | 2 | 2026 | 183 | 0.080 |
Why?
| | Cyclic AMP Receptor Protein | 1 | 2010 | 2 | 0.080 |
Why?
| | Weightlessness | 1 | 2010 | 39 | 0.080 |
Why?
| | Cells, Cultured | 4 | 2021 | 4146 | 0.080 |
Why?
| | Materials Testing | 2 | 2021 | 354 | 0.080 |
Why?
| | Protein Kinases | 1 | 2011 | 315 | 0.080 |
Why?
| | Cyclic AMP | 1 | 2010 | 208 | 0.080 |
Why?
| | Salmonella typhimurium | 2 | 2010 | 190 | 0.080 |
Why?
| | DNA Footprinting | 1 | 2009 | 33 | 0.070 |
Why?
| | Anaerobiosis | 4 | 2014 | 64 | 0.070 |
Why?
| | Fimbriae, Bacterial | 2 | 2010 | 36 | 0.070 |
Why?
| | Salmonella | 1 | 2008 | 61 | 0.070 |
Why?
| | Glycerol | 1 | 2008 | 90 | 0.070 |
Why?
| | Phosphates | 2 | 2008 | 179 | 0.070 |
Why?
| | Virulence Factors | 3 | 2017 | 172 | 0.070 |
Why?
| | Chromosome Mapping | 3 | 1997 | 509 | 0.060 |
Why?
| | Proteome | 2 | 2011 | 514 | 0.060 |
Why?
| | DNA, Mitochondrial | 1 | 1988 | 210 | 0.060 |
Why?
| | Polymerase Chain Reaction | 3 | 2021 | 1054 | 0.060 |
Why?
| | Electrophoresis, Gel, Two-Dimensional | 3 | 2008 | 110 | 0.060 |
Why?
| | Hydrogen-Ion Concentration | 3 | 2019 | 561 | 0.060 |
Why?
| | Lung Diseases | 3 | 2020 | 787 | 0.060 |
Why?
| | Real-Time Polymerase Chain Reaction | 2 | 2020 | 341 | 0.060 |
Why?
| | Gene Expression | 3 | 2021 | 1487 | 0.060 |
Why?
| | Skin | 2 | 2021 | 754 | 0.060 |
Why?
| | Mucin-1 | 1 | 2005 | 22 | 0.060 |
Why?
| | Bandages | 2 | 2015 | 42 | 0.060 |
Why?
| | Collagen Type IV | 1 | 2005 | 28 | 0.050 |
Why?
| | Laminin | 1 | 2005 | 72 | 0.050 |
Why?
| | Single-Strand Specific DNA and RNA Endonucleases | 1 | 2004 | 10 | 0.050 |
Why?
| | Mucin 5AC | 1 | 2005 | 70 | 0.050 |
Why?
| | Polymers | 2 | 2026 | 498 | 0.050 |
Why?
| | Sequence Alignment | 3 | 2011 | 366 | 0.050 |
Why?
| | Bioreactors | 1 | 2005 | 50 | 0.050 |
Why?
| | Tissue Culture Techniques | 1 | 2024 | 83 | 0.050 |
Why?
| | Electron Transport Complex IV | 1 | 2004 | 62 | 0.050 |
Why?
| | Mucins | 1 | 2005 | 76 | 0.050 |
Why?
| | Down-Regulation | 2 | 2020 | 627 | 0.050 |
Why?
| | Amoxicillin | 1 | 2023 | 35 | 0.050 |
Why?
| | Contact Lenses, Hydrophilic | 1 | 2003 | 6 | 0.050 |
Why?
| | Interleukins | 1 | 2005 | 248 | 0.050 |
Why?
| | Recombinant Fusion Proteins | 2 | 1996 | 674 | 0.050 |
Why?
| | Antigens, Neoplasm | 1 | 2005 | 271 | 0.050 |
Why?
| | Antigens | 1 | 2005 | 347 | 0.050 |
Why?
| | Phosphotransferases (Phosphomutases) | 1 | 2002 | 5 | 0.050 |
Why?
| | Hypochlorous Acid | 1 | 2002 | 8 | 0.050 |
Why?
| | Animal Husbandry | 1 | 2023 | 37 | 0.050 |
Why?
| | Glucose Oxidase | 1 | 2002 | 25 | 0.050 |
Why?
| | Glycoproteins | 1 | 2005 | 355 | 0.050 |
Why?
| | Ammonia | 1 | 2023 | 65 | 0.050 |
Why?
| | Sanitation | 1 | 2023 | 55 | 0.050 |
Why?
| | Housing, Animal | 1 | 2023 | 46 | 0.050 |
Why?
| | Thiazoles | 1 | 2023 | 135 | 0.050 |
Why?
| | Genotype | 1 | 2007 | 1833 | 0.050 |
Why?
| | Phenols | 1 | 2023 | 114 | 0.050 |
Why?
| | Movement | 1 | 2004 | 293 | 0.050 |
Why?
| | Peroxidase | 1 | 2002 | 168 | 0.050 |
Why?
| | Cell Culture Techniques | 1 | 2005 | 375 | 0.050 |
Why?
| | Dentistry | 1 | 2021 | 9 | 0.050 |
Why?
| | Chromatin Immunoprecipitation | 2 | 2013 | 139 | 0.040 |
Why?
| | Dentin | 1 | 2021 | 22 | 0.040 |
Why?
| | Dentin-Bonding Agents | 1 | 2021 | 14 | 0.040 |
Why?
| | Dental Cements | 1 | 2021 | 20 | 0.040 |
Why?
| | Adaptation, Physiological | 2 | 2004 | 569 | 0.040 |
Why?
| | Bisphenol A-Glycidyl Methacrylate | 1 | 2021 | 53 | 0.040 |
Why?
| | Protein Binding | 3 | 2014 | 2270 | 0.040 |
Why?
| | Tensile Strength | 1 | 2021 | 96 | 0.040 |
Why?
| | Pneumonia, Bacterial | 2 | 2013 | 113 | 0.040 |
Why?
| | Dental Materials | 1 | 2021 | 56 | 0.040 |
Why?
| | Iraq | 1 | 2021 | 65 | 0.040 |
Why?
| | Afghanistan | 1 | 2021 | 95 | 0.040 |
Why?
| | Amoxicillin-Potassium Clavulanate Combination | 1 | 2020 | 16 | 0.040 |
Why?
| | Specific Pathogen-Free Organisms | 1 | 2020 | 58 | 0.040 |
Why?
| | Signal Transduction | 4 | 2010 | 5221 | 0.040 |
Why?
| | Bacterial Capsules | 2 | 2002 | 33 | 0.040 |
Why?
| | Bacteremia | 1 | 2002 | 221 | 0.040 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2005 | 1217 | 0.040 |
Why?
| | Mutagenesis, Insertional | 4 | 2008 | 63 | 0.040 |
Why?
| | Mucus | 2 | 2006 | 73 | 0.040 |
Why?
| | Nanoparticles | 1 | 2026 | 519 | 0.040 |
Why?
| | Random Allocation | 1 | 2020 | 363 | 0.040 |
Why?
| | Drug Combinations | 1 | 2021 | 390 | 0.040 |
Why?
| | Dermis | 1 | 2019 | 32 | 0.040 |
Why?
| | Plankton | 1 | 2019 | 7 | 0.040 |
Why?
| | RNA, Ribosomal, 16S | 1 | 2022 | 558 | 0.040 |
Why?
| | Intention to Treat Analysis | 1 | 2019 | 79 | 0.040 |
Why?
| | Gases | 1 | 2019 | 53 | 0.040 |
Why?
| | Pruritus | 1 | 2019 | 59 | 0.040 |
Why?
| | Chlorine | 1 | 2019 | 64 | 0.040 |
Why?
| | Equipment Contamination | 1 | 2019 | 71 | 0.040 |
Why?
| | Osmolar Concentration | 2 | 1997 | 167 | 0.040 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 2 | 2013 | 981 | 0.040 |
Why?
| | Immunocompromised Host | 1 | 2020 | 201 | 0.040 |
Why?
| | Epidermis | 1 | 2019 | 157 | 0.040 |
Why?
| | Salvage Therapy | 1 | 2019 | 162 | 0.030 |
Why?
| | Transplantation, Autologous | 1 | 2019 | 290 | 0.030 |
Why?
| | Consciousness Disorders | 1 | 2018 | 23 | 0.030 |
Why?
| | Injury Severity Score | 1 | 2020 | 600 | 0.030 |
Why?
| | Soot | 1 | 2018 | 25 | 0.030 |
Why?
| | Facial Injuries | 1 | 2018 | 24 | 0.030 |
Why?
| | Hypercapnia | 1 | 2018 | 54 | 0.030 |
Why?
| | Smoke Inhalation Injury | 1 | 2018 | 30 | 0.030 |
Why?
| | Proteomics | 3 | 2010 | 1191 | 0.030 |
Why?
| | Animals, Newborn | 1 | 2020 | 901 | 0.030 |
Why?
| | Trauma Centers | 1 | 2020 | 462 | 0.030 |
Why?
| | Respiratory Sounds | 1 | 2018 | 105 | 0.030 |
Why?
| | Edema | 1 | 2018 | 124 | 0.030 |
Why?
| | Cloning, Molecular | 2 | 1995 | 539 | 0.030 |
Why?
| | Mice, Inbred BALB C | 2 | 2011 | 1253 | 0.030 |
Why?
| | Laryngoscopy | 1 | 2018 | 117 | 0.030 |
Why?
| | Adhesins, Bacterial | 2 | 2010 | 46 | 0.030 |
Why?
| | Multivariate Analysis | 1 | 2020 | 1533 | 0.030 |
Why?
| | Cell Line, Tumor | 1 | 2024 | 3539 | 0.030 |
Why?
| | Mutagenesis | 2 | 1994 | 190 | 0.030 |
Why?
| | Adult | 4 | 2021 | 40262 | 0.030 |
Why?
| | Drosophila | 1 | 2017 | 166 | 0.030 |
Why?
| | Deglutition Disorders | 1 | 2018 | 147 | 0.030 |
Why?
| | Periplasmic Proteins | 1 | 1996 | 3 | 0.030 |
Why?
| | Sulfur Radioisotopes | 1 | 1995 | 13 | 0.030 |
Why?
| | Polyvinyl Alcohol | 1 | 2015 | 18 | 0.030 |
Why?
| | Male | 6 | 2020 | 72035 | 0.030 |
Why?
| | Chemical Precipitation | 1 | 1995 | 38 | 0.030 |
Why?
| | Open Reading Frames | 1 | 1996 | 132 | 0.030 |
Why?
| | Electrolytes | 1 | 2015 | 55 | 0.030 |
Why?
| | Chronic Disease | 2 | 2019 | 1812 | 0.030 |
Why?
| | DNA Primers | 1 | 1996 | 511 | 0.030 |
Why?
| | Biomass | 1 | 2015 | 116 | 0.030 |
Why?
| | Fibroblasts | 1 | 2021 | 1032 | 0.030 |
Why?
| | Solubility | 1 | 2015 | 242 | 0.030 |
Why?
| | Isotope Labeling | 1 | 1995 | 82 | 0.030 |
Why?
| | Odds Ratio | 1 | 2018 | 1072 | 0.030 |
Why?
| | Logistic Models | 1 | 2020 | 2104 | 0.030 |
Why?
| | Serine Endopeptidases | 1 | 1996 | 128 | 0.030 |
Why?
| | Sequence Homology, Amino Acid | 4 | 1997 | 396 | 0.030 |
Why?
| | Genes, Suppressor | 1 | 1994 | 4 | 0.030 |
Why?
| | RNA, Bacterial | 1 | 1995 | 189 | 0.030 |
Why?
| | Rats | 1 | 2023 | 5592 | 0.030 |
Why?
| | Intensive Care Units | 1 | 2020 | 916 | 0.030 |
Why?
| | Lethal Dose 50 | 2 | 2008 | 15 | 0.030 |
Why?
| | Nitrogen Oxides | 1 | 2014 | 54 | 0.030 |
Why?
| | Agar | 1 | 2013 | 11 | 0.030 |
Why?
| | Incidence | 1 | 2020 | 2870 | 0.020 |
Why?
| | Biomarkers | 1 | 2005 | 4254 | 0.020 |
Why?
| | Genes, Reporter | 1 | 2014 | 275 | 0.020 |
Why?
| | Escherichia coli Proteins | 1 | 1995 | 206 | 0.020 |
Why?
| | Temperature | 1 | 1996 | 678 | 0.020 |
Why?
| | Keratinocytes | 1 | 2014 | 248 | 0.020 |
Why?
| | United States | 2 | 2021 | 15876 | 0.020 |
Why?
| | Drug Tolerance | 1 | 2013 | 100 | 0.020 |
Why?
| | Reactive Oxygen Species | 4 | 1997 | 621 | 0.020 |
Why?
| | Gene Knockout Techniques | 1 | 2013 | 116 | 0.020 |
Why?
| | Middle Aged | 3 | 2020 | 35762 | 0.020 |
Why?
| | Immunoblotting | 1 | 2013 | 300 | 0.020 |
Why?
| | Protein Multimerization | 1 | 2014 | 213 | 0.020 |
Why?
| | Fermentation | 1 | 2012 | 32 | 0.020 |
Why?
| | Young Adult | 2 | 2020 | 13990 | 0.020 |
Why?
| | Kinetics | 1 | 2015 | 1627 | 0.020 |
Why?
| | Histidine Kinase | 1 | 2011 | 34 | 0.020 |
Why?
| | Genetic Variation | 1 | 1997 | 982 | 0.020 |
Why?
| | Collagen | 1 | 2014 | 455 | 0.020 |
Why?
| | Viral Plaque Assay | 1 | 2011 | 29 | 0.020 |
Why?
| | Mice, Inbred C57BL | 1 | 2002 | 5988 | 0.020 |
Why?
| | Denitrification | 1 | 2010 | 5 | 0.020 |
Why?
| | Ecological Systems, Closed | 1 | 2010 | 5 | 0.020 |
Why?
| | Transcriptome | 1 | 2017 | 1044 | 0.020 |
Why?
| | Retrospective Studies | 2 | 2020 | 17009 | 0.020 |
Why?
| | Recombinant Proteins | 1 | 1994 | 1367 | 0.020 |
Why?
| | Lectins | 1 | 2010 | 44 | 0.020 |
Why?
| | Hypoxia | 1 | 2018 | 1199 | 0.020 |
Why?
| | Acute Disease | 1 | 2013 | 1028 | 0.020 |
Why?
| | Salmonella enterica | 1 | 2010 | 59 | 0.020 |
Why?
| | Adolescent | 2 | 2020 | 22281 | 0.020 |
Why?
| | Oxidative Stress | 1 | 1996 | 1339 | 0.020 |
Why?
| | 4-Butyrolactone | 1 | 2009 | 23 | 0.020 |
Why?
| | Oleic Acid | 1 | 2009 | 42 | 0.020 |
Why?
| | DNA Restriction Enzymes | 1 | 1988 | 53 | 0.020 |
Why?
| | Electrophoresis, Agar Gel | 1 | 1988 | 25 | 0.020 |
Why?
| | Ions | 1 | 2008 | 71 | 0.020 |
Why?
| | Membrane Proteins | 1 | 1995 | 1165 | 0.020 |
Why?
| | Mutagenesis, Site-Directed | 1 | 2009 | 381 | 0.020 |
Why?
| | Emergency Service, Hospital | 1 | 2020 | 2301 | 0.020 |
Why?
| | Bacteriophage Pf1 | 1 | 2008 | 2 | 0.020 |
Why?
| | Weightlessness Simulation | 1 | 2007 | 6 | 0.020 |
Why?
| | Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2008 | 143 | 0.020 |
Why?
| | Models, Molecular | 1 | 1993 | 1618 | 0.020 |
Why?
| | Salmonella Infections, Animal | 1 | 2007 | 39 | 0.020 |
Why?
| | Pregnancy | 1 | 2020 | 7180 | 0.020 |
Why?
| | RNA, Messenger | 1 | 1995 | 2829 | 0.020 |
Why?
| | Nitrates | 1 | 2008 | 100 | 0.020 |
Why?
| | Spectrum Analysis | 1 | 2007 | 93 | 0.020 |
Why?
| | DNA Transposable Elements | 1 | 2008 | 121 | 0.020 |
Why?
| | Protein Structure, Tertiary | 1 | 2009 | 862 | 0.020 |
Why?
| | Molecular Weight | 2 | 1997 | 327 | 0.010 |
Why?
| | Oxygen | 1 | 2010 | 995 | 0.010 |
Why?
| | Viral Proteins | 1 | 2008 | 355 | 0.010 |
Why?
| | Genetic Complementation Test | 2 | 1995 | 66 | 0.010 |
Why?
| | Treatment Outcome | 1 | 2019 | 11643 | 0.010 |
Why?
| | Sputum | 1 | 2006 | 308 | 0.010 |
Why?
| | Neutrophils | 1 | 2010 | 1134 | 0.010 |
Why?
| | Hot Temperature | 2 | 1997 | 405 | 0.010 |
Why?
| | Mice, Knockout | 1 | 2011 | 3119 | 0.010 |
Why?
| | Respiratory Mucosa | 1 | 2006 | 322 | 0.010 |
Why?
| | Morphogenesis | 2 | 1994 | 173 | 0.010 |
Why?
| | Colony Count, Microbial | 1 | 2003 | 122 | 0.010 |
Why?
| | Electric Impedance | 1 | 2003 | 111 | 0.010 |
Why?
| | Proteins | 1 | 1988 | 1021 | 0.010 |
Why?
| | Sequence Analysis, DNA | 2 | 1997 | 824 | 0.010 |
Why?
| | Cell Wall | 1 | 2002 | 61 | 0.010 |
Why?
| | Bacterial Toxins | 1 | 2002 | 108 | 0.010 |
Why?
| | Bacterial Infections | 1 | 2002 | 246 | 0.010 |
Why?
| | Nitrogen | 1 | 2000 | 170 | 0.010 |
Why?
| | Lipopolysaccharides | 1 | 2002 | 863 | 0.010 |
Why?
| | Aged | 1 | 2018 | 25850 | 0.010 |
Why?
| | Sodium Chloride | 1 | 1997 | 141 | 0.010 |
Why?
| | Suppression, Genetic | 1 | 1996 | 24 | 0.010 |
Why?
| | Transformation, Bacterial | 1 | 1995 | 9 | 0.010 |
Why?
| | Oligodeoxyribonucleotides | 1 | 1993 | 141 | 0.010 |
Why?
| | Recombination, Genetic | 1 | 1993 | 205 | 0.010 |
Why?
| | Models, Genetic | 1 | 1994 | 535 | 0.010 |
Why?
| | Infant | 1 | 2006 | 10022 | 0.010 |
Why?
| | Child, Preschool | 1 | 2006 | 11774 | 0.010 |
Why?
| | Alleles | 1 | 1993 | 878 | 0.000 |
Why?
| | Respiratory Tract Infections | 1 | 1993 | 396 | 0.000 |
Why?
| | Child | 1 | 2006 | 22537 | 0.000 |
Why?
|
|
Schurr's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|